EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway

Kai-Xin Zhang, Ning Sheng, Peng-Li Ding, Ji-Wei Zhang, Xiang-Qing Xu, Ya-Han Wang

Brain and Behavior · 2024

DOI: 10.1002/brb3.70056 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Kai-Xin Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Insulin Receptor Substrate Proteins, Drugs, Chinese Herbal, Glycogen Synthase Kinase 3 beta. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shandong Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Alzheimer's disease (AD) is a neurodegenerative disease characterized by Amyloid plaques and neurofibrillary tangles. We explored the potential mechanism by which Danggui Shaoyao San (DSS) modulates central glucose metabolism via the insulin receptor substrate 1 (IRS1)/glycogen synthase kinase‐3β (GSK3β)/Wnt3a‐β‐catenin pathway, thereby exerting protective effects on cognitive functions.

Methods

In vitro, HT22 cells were induced with streptozotocin (STZ) to investigate the impact of GSK3β on pathway transduction. The active components in the DSS stock solution were validated using mass spectrometry. Subsequently, an AD model in C57BL/6J mice was established through STZ injection into both ventricles. The success of the model was validated behaviorally and pathologically. The Morris Water Maze (MWM) test, immunohistochemistry, Western blotting, quantitative reverse transcription‐PCR, and 18F‐fluorodeoxyglucose‐positron emission tomography (FDG‐PET) were employed to evaluate the influence of DSS on memory and pathological changes in AD.

Results

The DSS stock solution, rich in active components, ameliorated the memory deficits in AD mice in the MWM. In vitro, GSK3β exhibited regulatory control over Wnt and β‐catenin, with GSK3β inhibition mitigating β‐amyloid and tau redundancies at protein and gene levels, facilitating signal transduction. In vivo, DSS impacted key targets in the IRS1/GSK3β/Wnt3a‐β‐catenin pathway, mitigated senile plaques resulting from amyloid β (Aβ) deposition and neurofiber tangles induced by tau hyperphosphorylation, and alleviated the decline in central glucose metabolism observed in FDG‐PET.

Conclusions

Our findings suggest that DSS potentially confers cognitive protection by alleviating central hypoglycemia through the IRS1/GSK3β/Wnt3a‐β‐catenin pathway. This may serve as a promising therapeutic avenue for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseInsulin Receptor Substrate ProteinsDrugs, Chinese HerbalGlycogen Synthase Kinase 3 betaWnt3A ProteinCognitive DysfunctionDisease Models, AnimalMice, Inbred C57BLAnimalsMiceMalebeta CateninWnt Signaling PathwaySignal Transduction

Stichwörter der Autor:innen

Alzheimer's diseaseDanggui Shaoyao Sancentral glucose metabolisminsulin receptor substrate 1 (IRS1)/glycogen synthase kinase‐3β (GSK3β)/Wnt3a‐β…

Substanzen

Insulin Receptor Substrate ProteinsDrugs, Chinese HerbalGlycogen Synthase Kinase 3 betaWnt3A Proteinbeta CateninIrs1 protein, mouseWnt3a protein, mouse

Autor:innen und Institutionen

  • First College of Clinical Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Beijing University of Chinese Medicine East Hospital, Zaozhuang Hospital, Zaozhuang, China.
  • College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • School of Acupuncture-Moxibustion and Tuina, Shandong University of Traditional Chinese Medicine, Jinan, China.
  • Department of Neurology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.

Förderung

  • Natural Science Foundation of Shandong Province
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, K. X., Sheng, N., Ding, P. L., Zhang, J. W., Xu, X. Q., & Wang, Y. H. (2024). Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway. Brain and Behavior. https://doi.org/10.1002/brb3.70056

Vancouver

Zhang KX, Sheng N, Ding PL, Zhang JW, Xu XQ, Wang YH. Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway. Brain and Behavior. 2024. doi:10.1002/brb3.70056

BibTeX
@article{Zhang2024,
  author = {Zhang, Kai-Xin and Sheng, Ning and Ding, Peng-Li and Zhang, Ji-Wei and Xu, Xiang-Qing and Wang, Ya-Han},
  title = {Danggui Shaoyao San Alleviates Early Cognitive Impairment in Alzheimer's Disease Mice Through IRS1/GSK3β/Wnt3a‐β‐Catenin Pathway},
  journal = {Brain and Behavior},
  year = {2024},
  doi = {10.1002/brb3.70056}
}
Kostenlos starten →